Should Cannabinoids Be Given to Kids With Cancer?
(MedPage Today) -- While cannabis-based products have become more popular for symptom management among children with cancer, evidence is lacking on the dosing, safety, and efficacy of cannabinoids in kids, according to researchers.
Of 19 studies... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 31, 2023 Category: Hematology Source Type: news
Concizumab Prophylaxis Reduced Bleeding Rates in Hemophilia
(MedPage Today) -- Compared with on-demand treatment, prophylaxis with concizumab -- designed to achieve hemostasis in all hemophilia types -- reduced annualized bleeding rates among patients who have hemophilia A or B with inhibitors, the... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 30, 2023 Category: Hematology Source Type: news
Novel Oral Tx Shows Early Promise in Relapsed/Refractory Myeloma
(MedPage Today) -- A novel protein-degrading agent exhibited promising activity in patients with relapsed/refractory multiple myeloma, results of a preliminary clinical trial showed.
Among 101 patients who received the recommended phase II dose... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 30, 2023 Category: Hematology Source Type: news
Novel Biomarker Boosts Diagnostic Accuracy of Nasopharyngeal Cancer Screening
(MedPage Today) -- A novel biomarker derived from Epstein-Barr virus (EBV) significantly improved the diagnostic accuracy for nasopharyngeal carcinoma, a large screening study from China showed.
Screening with P85-Ab, an anti-BNLF2b total antibody... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 30, 2023 Category: Hematology Source Type: news
Study Reinforces BRAF-MEK Inhibition Over Anti-BRAF Only in Advanced Melanoma
(MedPage Today) -- Combined BRAF-MEK inhibition for advanced BRAF-mutant melanoma led to significantly better progression-free survival (PFS) as compared with single-agent BRAF inhibition, according to a randomized trial.
Patients who received... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 29, 2023 Category: Hematology Source Type: news
